Here we attempt to summarize the mutual interactions between HDACs and oncogenic fusion proteins involved in AML, providing a reference for the precise application of HDAC inhibitors and novel drug exploration against AML. The gene discussed is HDAC9; the disease is acute myeloid leukemia.